Skip to main content
Clinical Trials/NCT05781581
NCT05781581
Not yet recruiting
Not Applicable

Main Postoperative Complications After SARS-CoV-2 Infection: A Retrospective Cohort Study

RenJi Hospital0 sites50,000 target enrollmentMarch 19, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Intestines Cancer
Sponsor
RenJi Hospital
Enrollment
50000
Primary Endpoint
All-cause mortality at 30 days after operation
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

To explore the relationship between SARS-CoV-2 infection in different time before operation and postoperative main complications (mortality, main pulmonary and cardiovascular complications) 30 days after operation; To determine the best timing of surgery after SARS-CoV-2 infection.

Registry
clinicaltrials.gov
Start Date
March 19, 2023
End Date
December 31, 2024
Last Updated
3 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Age≥18 years;
  • Patients undergoing any type of surgery in operating room.

Exclusion Criteria

  • Surgery under local anesthesia (without participation of anesthetist)
  • Surgery outside the operating room, such as gastrointestinal endoscopy, puncture biopsy, etc
  • Patients who cannot determine whether they have had SARS CoV-2 infection before surgery.

Outcomes

Primary Outcomes

All-cause mortality at 30 days after operation

Time Frame: 30 days after surgery

All-cause mortality at 30 days after operation

Secondary Outcomes

  • Main pulmonary complications at 30 days after operation(30 days after surgery)
  • Major Adverse Cardiovascular Events (MACE)(30 days after surgery)

Similar Trials